This report contains market size and forecasts of Cholesterol Medicines in global, including the following market information:
Global Cholesterol Medicines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cholesterol Medicines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cholesterol Medicines companies in 2021 (%)
The global Cholesterol Medicines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cholesterol Medicines include Pfizer Inc, Eli Lilly and Company, Abbott Laboratories, Merck & Co, Bristol-Myers Squibb Company, AstraZeneca, Amgen Inc, Novartis AG and GlaxoSmithKline and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cholesterol Medicines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cholesterol Medicines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cholesterol Medicines Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Global Cholesterol Medicines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cholesterol Medicines Market Segment Percentages, by Application, 2021 (%)
Cardiovascular Diseases
Liver Disease
Heart Disease
Others
Global Cholesterol Medicines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cholesterol Medicines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cholesterol Medicines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cholesterol Medicines revenues share in global market, 2021 (%)
Key companies Cholesterol Medicines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cholesterol Medicines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc
Eli Lilly and Company
Abbott Laboratories
Merck & Co
Bristol-Myers Squibb Company
AstraZeneca
Amgen Inc
Novartis AG
GlaxoSmithKline
Regeneron Pharmaceuticals